StockData

WORK Medical Technology Group LTD (WOK) company profile

WOKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jan 30, 2026Score 5/30
$1.19−0.04 (-3.08%)

Close on Nov 17, 2026Market cap $123.49MP/E –Yield –

About WORK Medical Technology

Surgical & Medical Instruments & Apparatus, SIC 3841

WORK Medical Technology Group LTD is an exempted holding company that operates primarily through its operating subsidiaries in China. Through these operating entities, the company engages in the research, development, manufacture, and commercialization of medical equipment and consumables. Its product offerings encompass Class I, Class II, and Class III medical devices, serving healthcare providers, distributors, and medical institutions.

The company maintains its operational footprint in the People's Republic of China, conducting business activities through multiple domestic subsidiaries situated across several regional locations, including Hangzhou, Shanghai, Huangshan, and Hunan. Additionally, it maintains an investment holding subsidiary established in Hong Kong. WORK Medical Technology Group LTD maintains its corporate headquarters and principal executive offices in Hangzhou City, Zhejiang Province, China.

Summary of the business section of WORK Medical Technology's latest annual report, written by StockData.

Company profile

Company

Legal name
WORK Medical Technology Group LTD
Headquarters
Auckland City, New Zealand
Address
1/88 Cook St 1001
Phone
86-0571-82613568
Employees
46, Sep 30, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
F4
Fiscal year ends
September 30
Auditor
HTL International, LLC, Houston, Texas

Stock & identifiers

Ticker
WOK
Exchange
Nasdaq
IPO date
Aug 26, 2024
Shares outstanding
104M, Sep 30, 2025
Filer category
Non-accelerated filer<br>Emerging growth company
Stock splits
1-for-972796 reverse, Aug 14, 2026; 1-for-100 reverse, Jun 18, 2026; 1-for-100 reverse, Dec 29, 2025; 1-for-100 reverse, Oct 21, 2025
SEC CIK
1929783
CUSIP
G9767H125
FIGI
BBG01GGXSRF7
Share class FIGI
BBG01GGXSS83
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Shuang Jarod WuCEO and Director–
Baiming YuCOO and Director100,625
Ningfang LiangChief Financial Officer–
Robert Brian JohnsonDirector–
Qisheng LinDirector–
Zhenguo WuDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Aug 26, 2024
Offer price
$4.00
Exchange
Nasdaq
First trading day
Aug 23, 2024
First-day close
$3.60-10.0%
Lock-up ends (est.)
Feb 19, 2025

“T he initial public offering price of the shares is $4.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“subsidiaries have a sales team of 46 employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jan 31, 2025Late filingNotification of late filing
Aug 26, 2024IPOInitial public offering priced (424B4 prospectus)
Aug 20, 2024ListingRegistration of securities on an exchange (Form 8-A)
Jun 23, 2022Name changeName changed from WORK Medical Technology LTD to WORK Medical Technology Group LTD

See a number that looks wrong?